Summary:
- The article discusses the appointment of Dr. Lawrence A. Tabak as the acting director of the National Institutes of Health (NIH), the largest public funder of biomedical research in the world.
- It highlights the challenges Tabak may face in reforming the NIH, such as addressing concerns about the agency's bureaucracy, funding allocation, and scientific integrity.
- The article also explores Tabak's background and his potential plans to improve the NIH's efficiency and transparency, which could have significant implications for the future of biomedical research in the United States.